Oxford Drug Design

📍 Oxford, United Kingdom🗓 Founded 2017👥 11 employees💰 Last funded Feb 2026
Biotechnology Research🌐 oxforddrugdesign.com
Website LinkedIn
Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Oxford Drug Design?
Oxford Drug Design has 1 investors on record on gritt.io and 1 late-stage investors.
When did Oxford Drug Design last raise funding?
The most recent investment in Oxford Drug Design recorded on gritt.io was in February 2026.
When was Oxford Drug Design founded?
Oxford Drug Design was founded in 2017.
What industry is Oxford Drug Design in?
Oxford Drug Design operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oxford Drug Design based?
Oxford Drug Design is headquartered in Oxford, United Kingdom.